Brind.
  1. Oragenics seeks FDA approval for a concussion treatment, having also secured HREC approval in Australia.

Oragenics secures a GMP production agreement with Sterling Pharma Solutions for its concussion drug candidate, ONP-002.

1 report, 1 independent Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Oragenics secures a GMP production agreement with Sterling Pharma Solutions for its concussion drug candidate, ONP-002.

Who's involved

What this event is mainly about
Oragenics (United States)GMP

Keep exploring

Part of

Oragenics seeks FDA approval for a concussion treatment, having also secured HREC approval in Australia. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireOragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a bi